{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:26:02Z","timestamp":1783905962616,"version":"3.55.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Systems Biology of Next Generation Company","award":["SBNGC14030925"],"award-info":[{"award-number":["SBNGC14030925"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52681-7","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:25:05Z","timestamp":1778585105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative transcriptomic analysis reveals novel targets for personalized medicine across seven metastatic breast cancer subtypes"],"prefix":"10.1038","volume":"16","author":[{"given":"Ali","family":"Salari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsham","family":"Mikaeili Namini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Sadat","family":"Shafiei Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasem","family":"Bagherpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Yosefy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delaram","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Mirzaei Chegeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Khodadad Hossyni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh","family":"Safari Kharkheshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monire","family":"Bakhshi Manjili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"52681_CR1","doi-asserted-by":"crossref","unstructured":"Patel, U., Susman, D. & Allan, A. L. Influence of extracellular vesicles on lung stromal cells during breast cancer metastasis. Int. J. Mol. Sci. 24 (14). (2023).","DOI":"10.3390\/ijms241411801"},{"key":"52681_CR2","doi-asserted-by":"crossref","unstructured":"Park, M. et al. Breast cancer metastasis: Mechanisms and therapeutic implications. Int. J. Mol. Sci. 23 (12). (2022).","DOI":"10.3390\/ijms23126806"},{"issue":"1","key":"52681_CR3","doi-asserted-by":"publisher","first-page":"e0260584","DOI":"10.1371\/journal.pone.0260584","volume":"17","author":"H Hozhabri","year":"2022","unstructured":"Hozhabri, H. et al. Comparative analysis of protein-protein interaction networks in metastatic breast cancer. PLoS One 17 (1), e0260584 (2022).","journal-title":"PLOS ONE"},{"key":"52681_CR4","doi-asserted-by":"publisher","first-page":"679262","DOI":"10.3389\/fonc.2021.679262","volume":"11","author":"L Xiao","year":"2021","unstructured":"Xiao, L. et al. RNA sequence profiling reveals unique immune and metabolic features of breast cancer brain metastases. Front. Oncol. 11, 679262 (2021).","journal-title":"Front. Oncol."},{"issue":"1","key":"52681_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molonc.2013.10.002","volume":"8","author":"S Kimbung","year":"2014","unstructured":"Kimbung, S. et al. Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences. Mol. Oncol. 8 (1), 119\u2013128 (2014).","journal-title":"Mol. Oncol."},{"issue":"1","key":"52681_CR6","doi-asserted-by":"publisher","first-page":"13343","DOI":"10.1038\/s41598-019-50099-y","volume":"9","author":"T Iwamoto","year":"2019","unstructured":"Iwamoto, T. et al. Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples. Sci. Rep. 9 (1), 13343 (2019).","journal-title":"Sci. Rep."},{"issue":"6","key":"52681_CR7","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T. et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28 (6), 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"issue":"2","key":"52681_CR8","first-page":"32","volume":"16","author":"LC Paul","year":"2013","unstructured":"Paul, L. C., Al Suman, A. & Sultan, N. Methodological analysis of principal component analysis (PCA) method. Int. J. Comput. Eng. Manag. 16 (2), 32\u201338 (2013).","journal-title":"Int. J. Comput. Eng. Manage."},{"key":"52681_CR9","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: elegant graphics for data analysis (Springer, 2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"issue":"7","key":"52681_CR10","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","volume":"32","author":"DM Gendoo","year":"2016","unstructured":"Gendoo, D. M. et al. Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer. Bioinformatics 32 (7), 1097\u20131099 (2016).","journal-title":"Bioinformatics"},{"issue":"D1","key":"52681_CR11","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M. et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"52681_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"suppl_1","key":"52681_CR13","doi-asserted-by":"publisher","first-page":"D258","DOI":"10.1093\/nar\/gkh036","volume":"32","author":"GO Consortium","year":"2004","unstructured":"Consortium, G. O. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 32 (suppl_1), D258\u2013D261 (2004).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"52681_CR14","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44 (W1), W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"52681_CR15","doi-asserted-by":"publisher","first-page":"W168","DOI":"10.1093\/nar\/gkad393","volume":"51","author":"JE Evangelista","year":"2023","unstructured":"Evangelista, J. E. et al. Enrichr-KG: bridging enrichment analysis across multiple libraries. Nucleic Acids Res. 51 (W1), W168\u2013W179 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"52681_CR16","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51 (D1), D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"52681_CR17","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13 (11), 2498\u20132504 (2003).","journal-title":"Genome Res."},{"issue":"21","key":"52681_CR18","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1093\/bioinformatics\/btp517","volume":"25","author":"G Scardoni","year":"2009","unstructured":"Scardoni, G., Petterlini, M. & Laudanna, C. Analyzing biological network parameters with CentiScaPe. Bioinformatics 25 (21), 2857\u20132859 (2009).","journal-title":"Bioinformatics"},{"issue":"2","key":"52681_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10549-013-2622-y","volume":"140","author":"Z Mih\u00e1ly","year":"2013","unstructured":"Mih\u00e1ly, Z. et al. A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer. Breast Cancer Res. Treat. 140 (2), 219\u2013232 (2013).","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"52681_CR20","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/annonc\/mdw320","volume":"27","author":"P Vuylsteke","year":"2016","unstructured":"Vuylsteke, P. et al. Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study. Ann. Oncol. 27 (11), 2059\u20132066 (2016).","journal-title":"Ann. Oncol."},{"issue":"11","key":"52681_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/14737140.2023.2245567","volume":"23","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Inhibition of neuroactive ligand-receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico study. Expert Rev. Anticancer Ther. 23 (11), 1205\u20131215 (2023).","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"1","key":"52681_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1079\/095442299108728857","volume":"12","author":"J Waterlow","year":"1999","unstructured":"Waterlow, J. The mysteries of nitrogen balance. Nutr. Res. Rev. 12 (1), 25\u201354 (1999).","journal-title":"Nutr. Res. Rev."},{"issue":"9","key":"52681_CR23","doi-asserted-by":"publisher","first-page":"e0137728","DOI":"10.1371\/journal.pone.0137728","volume":"10","author":"D Paul","year":"2015","unstructured":"Paul, D., Dasgupta, A. & De, R. K. Exploring the altered dynamics of mammalian central carbon metabolic pathway in cancer cells: a classical control theoretic approach. PLoS One. 10 (9), e0137728 (2015).","journal-title":"PLoS One"},{"key":"52681_CR24","doi-asserted-by":"crossref","unstructured":"Clevenger, C. V. & Rui, H. Breast cancer and prolactin - New mechanisms and models. Endocrinology 163 (10). (2022).","DOI":"10.1210\/endocr\/bqac122"},{"issue":"8","key":"52681_CR25","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1080\/01635581.2020.1795693","volume":"73","author":"KL Machado","year":"2021","unstructured":"Machado, K. L. et al. Oxidative stress in caffeine action on the proliferation and death of human breast cancer cells MCF-7 and MDA-MB-231. Nutr. Cancer. 73 (8), 1378\u20131388 (2021).","journal-title":"Nutr. Cancer"},{"key":"52681_CR26","doi-asserted-by":"crossref","unstructured":"Halada, S. et al. Hormonal crosstalk between thyroid and breast cancer. Endocrinology 163 (7). (2022).","DOI":"10.1210\/endocr\/bqac075"},{"issue":"1","key":"52681_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward, J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer. 3 (1), 11\u201322 (2003).","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"52681_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","volume":"19","author":"SR Punekar","year":"2022","unstructured":"Punekar, S. R. et al. The current state of the art and future trends in RAS-targeted cancer therapies. Nat. Reviews Clin. Oncol. 19 (10), 637\u2013655 (2022).","journal-title":"Nat. Reviews Clin. Oncol."},{"issue":"4","key":"52681_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.canep.2014.05.005","volume":"38","author":"M Harries","year":"2014","unstructured":"Harries, M. et al. Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients. Cancer Epidemiol. 38 (4), 427\u2013434 (2014).","journal-title":"Cancer Epidemiol."},{"key":"52681_CR30","doi-asserted-by":"crossref","unstructured":"Drohan, A. et al. Cutaneous breast cancer metastasis is effectively treated with intralesional interleukin-2 and imiquimod: A case report and brief literature review. Front. Oncol., 12. (2022).","DOI":"10.3389\/fonc.2022.877014"},{"issue":"1","key":"52681_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12885-021-08969-0","volume":"22","author":"T Mikkola","year":"2022","unstructured":"Mikkola, T. et al. Variable roles of interleukin-17F in different cancers. BMC Cancer. 22 (1), 54 (2022).","journal-title":"BMC Cancer"},{"key":"52681_CR32","doi-asserted-by":"crossref","unstructured":"Dituri, F. et al. Proteoglycans in cancer: Friends or enemies? A special focus on hepatocellular carcinoma. Cancers (Basel) 14 (8). (2022).","DOI":"10.3390\/cancers14081902"},{"key":"52681_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2019.07.012","volume":"62","author":"NA Espinoza-S\u00e1nchez","year":"2020","unstructured":"Espinoza-S\u00e1nchez, N. A. & G\u00f6tte, M. Role of cell surface proteoglycans in cancer immunotherapy. Sem. Cancer Biol. 62, 48\u201367 (2020).","journal-title":"Sem. Cancer Biol."},{"issue":"1","key":"52681_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12935-019-1027-3","volume":"19","author":"R Zhang","year":"2019","unstructured":"Zhang, R. et al. Role of the complement system in the tumor microenvironment. Cancer Cell Int. 19 (1), 300 (2019).","journal-title":"Cancer Cell Int."},{"issue":"1","key":"52681_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.21037\/tcr-23-906","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade glioma. Translational Cancer Res. 13 (1), 112\u2013136 (2024).","journal-title":"Translational Cancer Res."},{"issue":"6","key":"52681_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.smim.2016.10.011","volume":"28","author":"S Guglietta","year":"2016","unstructured":"Guglietta, S. & Rescigno, M. Hypercoagulation and complement: Connected players in tumor development and metastases. Semin. Immunol. 28 (6), 578\u2013586 (2016).","journal-title":"Semin. Immunol."},{"issue":"6","key":"52681_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41419-021-03895-2","volume":"12","author":"Y Yuan","year":"2021","unstructured":"Yuan, Y. et al. H2A. Z acetylation by lincZNF337-AS1 via KAT5 implicated in the transcriptional misregulation in cancer signaling pathway in hepatocellular carcinoma. Cell Death Dis. 12 (6), 609 (2021).","journal-title":"Cell Death Dis."},{"issue":"47","key":"52681_CR38","doi-asserted-by":"publisher","first-page":"eabn0238","DOI":"10.1126\/sciadv.abn0238","volume":"8","author":"M Zatzman","year":"2022","unstructured":"Zatzman, M. et al. Widespread hypertranscription in aggressive human cancers. Sci. Adv. 8 (47), eabn0238 (2022).","journal-title":"Sci. Adv."},{"issue":"12","key":"52681_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.tcb.2013.06.001","volume":"23","author":"B Ell","year":"2013","unstructured":"Ell, B. & Kang, Y. Transcriptional control of cancer metastasis. Trends Cell. Biol. 23 (12), 603\u2013611 (2013).","journal-title":"Trends Cell. Biol."},{"issue":"3","key":"52681_CR40","doi-asserted-by":"publisher","first-page":"e1807","DOI":"10.1371\/journal.pone.0001807","volume":"3","author":"A Dahlgren","year":"2008","unstructured":"Dahlgren, A. et al. Association of the estrogen receptor 1 (ESR1) gene with body height in adult males from two Swedish population cohorts. PLoS One. 3 (3), e1807 (2008).","journal-title":"PLoS One"},{"issue":"10","key":"52681_CR41","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/ijc.29612","volume":"137","author":"D Sefrioui","year":"2015","unstructured":"Sefrioui, D. et al. Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer. Int. J. Cancer. 137 (10), 2513\u20132519 (2015).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"52681_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13058-020-1246-5","volume":"22","author":"A Zundelevich","year":"2020","unstructured":"Zundelevich, A. et al. ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis. Breast Cancer Res. 22 (1), 16 (2020).","journal-title":"Breast Cancer Res."},{"issue":"5","key":"52681_CR43","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1086\/515582","volume":"80","author":"J Amiel","year":"2007","unstructured":"Amiel, J. et al. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am. J. Hum. Genet. 80 (5), 988\u2013993 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"52681_CR44","doi-asserted-by":"crossref","unstructured":"Tu, W. et al. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2\/CCR2 signaling. Cell Death Dis. 12 (10), 882 (2021).","DOI":"10.1038\/s41419-021-04166-w"},{"issue":"1","key":"52681_CR45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41420-024-01936-1","volume":"10","author":"N Liu","year":"2024","unstructured":"Liu, N. et al. FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer. Cell. Death Discov. 10 (1), 172 (2024).","journal-title":"Cell. Death Discovery"},{"issue":"2","key":"52681_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12282-021-01305-1","volume":"29","author":"B Li","year":"2022","unstructured":"Li, B. et al. FOXA1 of regulatory variant associated with risk of breast cancer through allele-specific enhancer in the Chinese population. Breast Cancer. 29 (2), 247\u2013259 (2022).","journal-title":"Breast Cancer"},{"issue":"33","key":"52681_CR47","doi-asserted-by":"publisher","first-page":"eadg7112","DOI":"10.1126\/sciadv.adg7112","volume":"9","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. FOXA1 O-GlcNAcylation\u2013mediated transcriptional switch governs metastasis capacity in breast cancer. Sci. Adv. 9 (33), eadg7112 (2023).","journal-title":"Sci. Adv."},{"issue":"2","key":"52681_CR48","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/1055-9965.EPI-06-1090","volume":"17","author":"D Voduc","year":"2008","unstructured":"Voduc, D., Cheang, M. & Nielsen, T. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol. Biomarkers Prev. 17 (2), 365\u2013373 (2008).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"52681_CR49","doi-asserted-by":"publisher","first-page":"153611","DOI":"10.1016\/j.prp.2021.153611","volume":"226","author":"MK Najafabadi","year":"2021","unstructured":"Najafabadi, M. K. et al. Role of GATA3 in tumor diagnosis: A review. Pathol. Res. Pract. 226, 153611 (2021).","journal-title":"Pathology-Research Pract."},{"issue":"17","key":"52681_CR50","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.7150\/thno.59280","volume":"11","author":"F Bai","year":"2021","unstructured":"Bai, F. et al. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer. Theranostics 11 (17), 8218 (2021).","journal-title":"Theranostics"},{"issue":"2","key":"52681_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/jmedgenet-2021-108105","volume":"59","author":"V Pingault","year":"2022","unstructured":"Pingault, V. et al. SOX10: 20 years of phenotypic plurality and current understanding of its developmental function. J. Med. Genet. 59 (2), 105\u2013114 (2022).","journal-title":"J. Med. Genet."},{"key":"52681_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-020-05818-9","volume":"184","author":"C Aphivatanasiri","year":"2020","unstructured":"Aphivatanasiri, C. et al. Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors. Breast Cancer Res. Treat. 184, 11\u201321 (2020).","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"52681_CR53","doi-asserted-by":"publisher","first-page":"19026","DOI":"10.1038\/s41598-022-23750-4","volume":"12","author":"Q Kanyomse","year":"2022","unstructured":"Kanyomse, Q. et al. KLF15 suppresses tumor growth and metastasis in Triple-negative breast cancer by downregulating CCL2 and CCL7. Sci. Rep. 12 (1), 19026 (2022).","journal-title":"Sci. Rep."},{"key":"52681_CR54","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fendo.2020.00573","volume":"11","author":"M Chen","year":"2020","unstructured":"Chen, M. et al. Androgen receptor in breast cancer: From bench to bedside. Front. Endocrinol. (Lausanne). 11, 573 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"46","key":"52681_CR55","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1038\/s41388-021-02030-x","volume":"40","author":"CJ Block","year":"2021","unstructured":"Block, C. J. et al. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA. Oncogene 40 (46), 6430\u20136442 (2021).","journal-title":"Oncogene"},{"key":"52681_CR56","doi-asserted-by":"crossref","unstructured":"Pa\u00e7o, A. et al. Roles of the HOX proteins in cancer invasion and metastasis. Cancers (Basel) 13 (1). (2020).","DOI":"10.3390\/cancers13010010"},{"key":"52681_CR57","unstructured":"Chen, X. et al. MiR-326 regulates EphB3 to inhibit invasion and metastasis of breast cancer cells. Chin. Pharmacol. Bull. pp. 665\u2013672. (2023)."},{"key":"52681_CR58","doi-asserted-by":"crossref","unstructured":"Arabkari, V. et al. miRNA-378 is downregulated by XBP1 and inhibits growth and migration of luminal breast cancer cells. Int. J. Mol. Sci. 25 (1). (2023).","DOI":"10.3390\/ijms25010186"},{"key":"52681_CR59","doi-asserted-by":"crossref","unstructured":"Yang, T. et al. COL6A1 inhibits the malignant development of bladder cancer by regulating FBN1. Cell Biochem. Biophys. pp. 1\u201313. (2024).","DOI":"10.1007\/s12013-024-01573-6"},{"key":"52681_CR60","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. Comprehensive analysis of the expression and prognostic significance of THBSs in breast cancer. (2021).","DOI":"10.21203\/rs.3.rs-620437\/v1"},{"issue":"6907","key":"52681_CR61","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nature01101","volume":"419","author":"VS Marsden","year":"2002","unstructured":"Marsden, V. S. et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c\/Apaf-1\/caspase-9 apoptosome. Nature 419 (6907), 634\u2013637 (2002).","journal-title":"Nature"},{"issue":"6","key":"52681_CR62","first-page":"8991","volume":"15","author":"C Du","year":"2018","unstructured":"Du, C. et al. Bcl\u20132 promotes metastasis through the epithelial\u2013to\u2013mesenchymal transition in the BCap37 medullary breast cancer cell line. Oncol. Lett. 15 (6), 8991\u20138898 (2018).","journal-title":"Oncol. Lett."},{"key":"52681_CR63","doi-asserted-by":"crossref","unstructured":"Kundu, G. & Elangovan, S. Investigating the role of SPP1 (Osteopontin) in the progression of breast and other cancers. (2024).","DOI":"10.20944\/preprints202410.1898.v1"},{"key":"52681_CR64","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1016\/j.csbj.2023.11.018","volume":"21","author":"T Chen","year":"2023","unstructured":"Chen, T. et al. Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages. Comput. Struct. Biotechnol. J. 21, 5751\u20135764 (2023).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"52681_CR65","doi-asserted-by":"publisher","first-page":"108454","DOI":"10.1016\/j.intimp.2021.108454","volume":"103","author":"Y Shen","year":"2022","unstructured":"Shen, Y. et al. CXCL8 is a prognostic biomarker and correlated with TNBC brain metastasis and immune infiltration. Int. Immunopharmacol. 103, 108454 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"52681_CR66","doi-asserted-by":"publisher","first-page":"101733","DOI":"10.1016\/j.tranon.2023.101733","volume":"35","author":"L Li","year":"2023","unstructured":"Li, L. et al. Cancer stem cells promote lymph nodes metastasis of breast cancer by reprogramming tumor microenvironment. Translational Oncol. 35, 101733 (2023).","journal-title":"Translational Oncol."},{"key":"52681_CR67","doi-asserted-by":"publisher","unstructured":"Xu, K. et al. Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis. Oncogenesis 10, 66. https:\/\/doi.org\/10.1038\/s41389-021-00355-6 (2021).","DOI":"10.1038\/s41389-021-00355-6"},{"issue":"19","key":"52681_CR68","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1158\/0008-5472.CAN-14-0067","volume":"74","author":"L Volk-Draper","year":"2014","unstructured":"Volk-Draper, L. et al. Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. Cancer Res. 74 (19), 5421\u20135434 (2014).","journal-title":"Cancer Res."},{"key":"52681_CR69","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/BF03183956","volume":"48","author":"J Fang","year":"2003","unstructured":"Fang, J. et al. Role of FGF-2\/FGFR signaling pathway in cancer and its signification in breast cancer. Chin. Sci. Bull. 48, 1539\u20131547 (2003).","journal-title":"Chin. Sci. Bull."},{"issue":"6","key":"52681_CR70","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/cells8060540","volume":"8","author":"M Czyz","year":"2019","unstructured":"Czyz, M. Fibroblast growth factor receptor signaling in skin cancers. Cells 8 (6), 540 (2019).","journal-title":"Cells"},{"issue":"6","key":"52681_CR71","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10585-004-3503-x","volume":"21","author":"C Suarez-Cuervo","year":"2004","unstructured":"Suarez-Cuervo, C. et al. Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin. Exp. Metastasis. 21 (6), 525\u2013533 (2004).","journal-title":"Clin. Exp. Metastasis"},{"key":"52681_CR72","doi-asserted-by":"publisher","first-page":"115139","DOI":"10.1016\/j.bone.2019.115139","volume":"130","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9. Bone 130, 115139 (2020).","journal-title":"Bone"},{"key":"52681_CR73","doi-asserted-by":"publisher","first-page":"866014","DOI":"10.3389\/fonc.2022.866014","volume":"12","author":"SG Manore","year":"2022","unstructured":"Manore, S. G. et al. IL-6\/JAK\/STAT3 signaling in breast cancer metastasis: biology and treatment. Front. Oncol. 12, 866014 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"52681_CR74","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2005.06.021","volume":"238","author":"KE Luker","year":"2006","unstructured":"Luker, K. E. & Luker, G. D. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett. 238 (1), 30\u201341 (2006).","journal-title":"Cancer Lett."},{"issue":"7","key":"52681_CR75","doi-asserted-by":"publisher","first-page":"bqab049","DOI":"10.1210\/endocr\/bqab049","volume":"162","author":"J Li","year":"2021","unstructured":"Li, J. et al. Vitamin D regulates CXCL12\/CXCR4 and epithelial-to-mesenchymal transition in a model of breast cancer metastasis to lung. Endocrinology 162 (7), bqab049 (2021).","journal-title":"Endocrinology"},{"issue":"4_Supplement","key":"52681_CR76","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1158\/1538-7445.SABCS19-P3-01-06","volume":"80","author":"X Hu","year":"2020","unstructured":"Hu, X. et al. Abstract P3-01-06: Decorin-mediated suppression of tumorigenesis and skin invasion in inflammatory breast cancer via inhibition of the E-cadherin\/EGFR axis. Cancer Res. 80 (4_Supplement), P3\u201301 (2020).","journal-title":"Cancer Res."},{"issue":"2","key":"52681_CR77","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000228253","volume":"77","author":"K Araki","year":"2008","unstructured":"Araki, K. et al. Decorin suppresses bone metastasis in a breast cancer cell line. Oncology 77 (2), 92\u201399 (2008).","journal-title":"Oncology"},{"key":"52681_CR78","doi-asserted-by":"crossref","unstructured":"Shao, T. M. et al. Screening and identification of key biomarkers in breast cancer with brain metastasis: Evidence from bioinformatic analysis. (2020).","DOI":"10.21203\/rs.3.rs-38542\/v1"},{"issue":"3B","key":"52681_CR79","first-page":"1519","volume":"27","author":"L Incorvaia","year":"2007","unstructured":"Incorvaia, L. et al. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. Anticancer Res. 27 (3B), 1519\u20131525 (2007).","journal-title":"Anticancer Res."},{"key":"52681_CR80","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10585-007-9071-0","volume":"24","author":"O Mendes","year":"2007","unstructured":"Mendes, O. et al. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1\/2. Clin. Exp. Metastasis. 24, 341\u2013351 (2007).","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"52681_CR81","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1593\/neo.121726","volume":"15","author":"EJ Steller","year":"2013","unstructured":"Steller, E. J. et al. PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells. Neoplasia 15 (2), 204\u2013IN30 (2013).","journal-title":"Neoplasia"},{"issue":"25","key":"52681_CR82","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1038\/s41388-019-0773-y","volume":"38","author":"A Bernat-Peguera","year":"2019","unstructured":"Bernat-Peguera, A. et al. PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma. Oncogene 38 (25), 5021\u20135037 (2019).","journal-title":"Oncogene"},{"issue":"1","key":"52681_CR83","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s42003-023-05124-2","volume":"6","author":"Q Song","year":"2023","unstructured":"Song, Q. et al. Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment. Commun. Biol. 6 (1), 760 (2023).","journal-title":"Commun. Biol."},{"issue":"139","key":"52681_CR84","first-page":"211","volume":"25","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov. Med. 25 (139), 211\u2013223 (2018).","journal-title":"Discov. Med."},{"issue":"1","key":"52681_CR85","doi-asserted-by":"publisher","first-page":"18566","DOI":"10.1038\/s41598-023-45832-7","volume":"13","author":"R Cai","year":"2023","unstructured":"Cai, R. et al. Primary breast tumor induced extracellular matrix remodeling in premetastatic lungs. Sci. Rep. 13 (1), 18566 (2023).","journal-title":"Sci. Rep."},{"issue":"7","key":"52681_CR86","doi-asserted-by":"publisher","first-page":"e32771","DOI":"10.1097\/MD.0000000000032771","volume":"102","author":"XG Li","year":"2023","unstructured":"Li, X. G. et al. Screening and identification of hub-gene associated with brain metastasis in breast cancer. Medicine 102 (7), e32771 (2023).","journal-title":"Medicine"},{"key":"52681_CR87","doi-asserted-by":"crossref","unstructured":"Ma, H. P. et al. Collagen 1A1 (COL1A1) is a reliable biomarker and putative therapeutic target for hepatocellular carcinogenesis and metastasis. Cancers (Basel) 11 (6). (2019).","DOI":"10.3390\/cancers11060786"},{"key":"52681_CR88","doi-asserted-by":"publisher","first-page":"1037531","DOI":"10.3389\/fonc.2022.1037531","volume":"12","author":"Z Nagy","year":"2022","unstructured":"Nagy, Z. & Jeselsohn, R. ESR1 fusions and therapeutic resistance in metastatic breast cancer. Front. Oncol. 12, 1037531 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"52681_CR89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41523-019-0104-z","volume":"5","author":"C Desmedt","year":"2019","unstructured":"Desmedt, C. et al. ESR1 mutations in metastatic lobular breast cancer patients. NPJ Breast Cancer. 5 (1), 9 (2019).","journal-title":"NPJ breast cancer"},{"issue":"4","key":"52681_CR90","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/ejso.2002.1259","volume":"28","author":"S Tsutsui","year":"2002","unstructured":"Tsutsui, S. et al. EGFR, c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer. Eur. J. Surg. Oncol. 28 (4), 383\u2013387 (2002).","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"52681_CR91","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000331417","volume":"81","author":"JH Kong","year":"2011","unstructured":"Kong, J. H. et al. Patterns of skin and soft tissue metastases from breast cancer according to subtypes: relationship between EGFR overexpression and skin manifestations. Oncology 81 (1), 55\u201362 (2011).","journal-title":"Oncology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52681-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52681-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52681-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:01:43Z","timestamp":1783904503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52681-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52681"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52681-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21716"}}